Marsh & McLennan Companies stock
Price history
+14.83% over the period1 year: from $180.87 (November 17, 2025) to $207.69 (November 17, 2026), +14.83%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 17, 2026 | $207.69 |
| October 30, 2026 | $200.62 |
| September 30, 2026 | $170.73 |
| August 31, 2026 | $189.80 |
| July 31, 2026 | $189.69 |
| June 30, 2026 | $166.67 |
| May 29, 2026 | $159.97 |
| April 30, 2026 | $167.71 |
| March 31, 2026 | $173.45 |
| February 27, 2026 | $186.74 |
| January 30, 2026 | $188.19 |
| December 31, 2025 | $185.52 |
| November 28, 2025 | $183.45 |
| November 17, 2025 | $180.87 |
At a glance
The company
Professional services firm providing risk management, insurance brokerage, consulting and advisory services to businesses and organizations worldwide
Latest results
Quarter to September 30, 2026 · EPS $2.03 (estimate $1.97)
Next event
TickerLandia's take on Marsh & McLennan Companies
- Priced as usual relative to earnings: P/E on the latest fiscal year 25 vs a median of 27 over its last 10 fiscal years.
- Priced in line with similar companies: trailing 12-month P/E 23 vs 24 (−3%) in a group of 10.
- Strong point: Market momentum (77/100 in its group). Weak point: Growth (45/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
+2.87% from the 52-week high
Analysts · 23 analysts
Average target$205.38−0.33% vs. price
Buy 7 · Hold 15 · Sell 1 · Hold
TickerLandia Fingerprint: Marsh & McLennan Companies
Compared with similar companies: very low risk.
Financials and price compared with 10 companies in the insurance brokers industry, worldwide. Momentum and risk compared with 883 North American stocks.
Priceaverage48
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 22.9 45 Price/sales 3.25 25 Forward P/E 18.5 55 Price/book 6.31 65 Profitabilityhigh63
How much it earns on revenue and capital.
Metric Value Position in group Operating margin 24.5% 45 Net margin 14.2% 55 ROE 27.2% 75 ROA 7.3% 75 Earnings stabilityhigh73
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 1.3% 85 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 60 Growthaverage45
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +9.20% 15 Revenue growth (year over year) +8.06% 55 Earnings growth (year over year) +11.92% 65 Financial strengthdoes not apply to banks and insurers
How well it would weather a hard period: debt, liquidity, interest.
Dividendhigh63
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years at least 37 years 75 Dividend yield 2.1% 56 Payout ratio 45.3% 56 Market momentumstrong77
How the stock has moved compared with the market.
Metric Value Position in group 1-year return +13.93% 53 Distance from 200-day average +15.37% 86 Relative strength (3 months) +16.82% 85 Relative strength (6 months) +27.81% 86 Riskvery low14
How much the price swings.
Metric Value Position in group Volatility (60 days) 24.1% 21 Beta (1 year) −0.30 5 Maximum drawdown (12 months) 17.1% 16
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 18, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Marsh & McLennan Companies is priced as in the past and in line with similar companies
On the latest fiscal year's earnings (2025), Marsh & McLennan Companies's P/E today is 24.6, in line with the median of its last 10 fiscal years (26.7; between 20.0 and 32.7 from 2016 to 2025). Marsh & McLennan Companies's P/E (trailing 12 months): 22.9, in line with the median of a group of 10 similar companies (23.5).
Compared with 10 similar companies
| Metric | Marsh & McLennan Companies | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 22.9 | Middle | |
| Forward P/E | 18.5 | Middle | |
| ROE | 27.2% | High | |
| Price/book | 6.31 | Middle |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Marsh & McLennan Companies. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
$6.86B
Latest quarter · Q3 2026
Net income
$808M
Latest quarter · Q3 2026
Quarterly net margin
11.8%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- $91.44B
- P/E
- 22.9
- EPS
- $8.35
- Volume
- 2.4M
- Daily trading
- €407.54M
- Dividend yield
- 1.83%
- Last ex-dividend on October 1, 2026
How Marsh & McLennan Companies is changing
All resultsRevenue grew 9.4% a year on average over the last 5 years
Shares outstanding down 3.5% in 5 years
Revenue has grown for 9 fiscal years in a row
Returns
Marsh & McLennan Companies returns with dividends
$1,000 invested in Marsh & McLennan Companies 5 years ago, on November 17, 2021, would be worth $1,341 today with dividends reinvested: +34.09% in total, +6.04% per year. On price alone it would be $1,238 (+23.78%).
| Period | Marsh & McLennan Companies | S&P 500 | $1,000 becomes |
|---|---|---|---|
| 1 month | +10.18% | −3.17% | $1,102 |
| 6 months | +27.95% | +0.11% | $1,280 |
| Year to date | +11.95% | +8.34% | $1,120 |
| 1 year | +17.30% | +11.15% | $1,173 |
| 3 years | +10.53% | +64.30% | $1,105 |
| 5 years | +34.09% | +58.18% | $1,341 |
| 10 years | +256.03% | +239.10% | $3,560 |
Over the last 6 months it has done better than 96% of the stocks in the Finance sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. S&P 500: price only. Calculate your investment
The chart in detail
Marsh & McLennan Companies: technical analysis
Marsh & McLennan Companies is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 15.6% below its highest close since January 2, 1990 ($244.27, April 3, 2025).
- Trend
- Upward
- RSI (14 sessions)
- 61
- Between 30 and 70
- vs 200-session average
- +15.37%
Support and resistance
Price areas where Marsh & McLennan Companies has stopped several times in the last year. They describe the chart; they are not forecasts.
- No resistance above: the price is near the highs of the year
- Last price$206.07
- Support$188.18−8.68%4 touches, last on February 27, 2026
- Support$184.28−10.58%3 touches, last on August 17, 2026
- Support$179.59−12.85%3 touches, last on March 23, 2026
Volatility and risk
Over the last year it has often moved in the opposite direction to the S&P 500.
- Beta (1 year) vs S&P 500
- −0.30
- Volatility (60 sessions, annualised)
- 24.1%
- Largest fall in the last year
- −17.09%
Close of November 17, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Marsh & McLennan Companies: seasonality
Average monthly price change over 37 years
Over the last 37 years, the strongest month for Marsh & McLennan Companies has been November: +2.50% on average, positive in 24 years out of 36. The weakest has been January: −1.53% on average, positive in 16 years out of 36.
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | −1.53% | −0.60% | 16 of 36 |
| February | +2.28% | +2.82% | 25 of 37 |
| March | +1.60% | +0.72% | 23 of 37 |
| April | +0.72% | +0.42% | 23 of 37 |
| May | +1.31% | +1.39% | 21 of 37 |
| June | +0.43% | +1.37% | 21 of 37 |
| July | +1.29% | +0.48% | 23 of 37 |
| August | +0.08% | +0.77% | 22 of 37 |
| September | −0.29% | −0.56% | 16 of 37 |
| October | +0.30% | +0.29% | 20 of 37 |
| November | +2.50% | +3.65% | 24 of 36 |
| December | +1.60% | +1.14% | 23 of 36 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Marsh & McLennan Companies and its competitors
Headquartered in New York and in business since 1871, the group brokers insurance and reinsurance and advises corporations and public bodies on the risks they face. Its clients range from companies and insurers to trade associations, professional firms and private individuals. A second business line sells consulting on health, wealth and careers, along with management, economic and brand work. By revenue, the United States accounts for 49.2%, the United Kingdom for 14.1% and other markets for 36.5%.
- Headquarters
- New York, United States
- Employees
- 95,000
- Founded
- 1871
- Chief executive
- John Doyle
| Company | Market cap | ROE | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Marsh & McLennan CompaniesMRSH | $91.44B | 27.2% | 22.9 | +27.95% |
| Arthur J. GallagherAJG | $72.55B | 7.2% | 43.2 | +41.48% |
| AonAON | $67B | 43.4% | 17.4 | +5.54% |
| Willis Towers Watson PublicWTW | $31.18B | 20.2% | 20.8 | +33.25% |
| Brown & BrownBRO | $23.67B | 9.8% | 22.5 | +28.38% |
| Erie IndemnityERIE | $12.88B | 24.8% | 22.1 | +28.10% |
Same industry or related industries, similar size. Compare Marsh & McLennan Companies with its competitors · Full profile
More on Marsh & McLennan Companies
- Marsh & McLennan Companies revenue and financials
- Marsh & McLennan Companies dividend and valuation
- Marsh & McLennan Companies stock return
- Marsh & McLennan Companies employees, headquarters and business
